Performance of Two Silicone Hydrogel Toric Contact Lenses
- Conditions
- Vision Correction
- Interventions
- Device: balafilcon A toricDevice: senofilcon A toric
- Registration Number
- NCT00638846
- Lead Sponsor
- Johnson & Johnson Vision Care, Inc.
- Brief Summary
Evaluation of the clinical performance of two toric contact lenses in a 2-week, single masked (subject), daily wear, randomized, bilateral, parallel group study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 276
-
Be between 18 and 45 years of age.
-
Sign Written Informed Consent (See separate document).
-
Be an existing successful daily wear toric soft contact lens.
-
Require a visual correction in both eyes (monovision or uniocular fitting is NOT allowed).
-
Does not require presbyopic correction (can read J1 @ normal reading distance).
-
Have a sphere requirement in the range -1.00 and -5.00D (-5.25D refractive)
-
Have refractive astigmatism between 0.75D and 2.50D in both eyes.
-
Achieve visual acuity of 20/30 or better in each eye with spherical distance correction.
-
Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:
- No amblyopia.
- No evidence of lid abnormality or infection.
- No conjunctival abnormality or infection.
- No clinically significant slit lamp findings (i.e. stromal edema, vascularisation, infiltrates or abnormal opacities).
- No other active ocular disease.
- Requires concurrent ocular medication.
- Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
- Corneal staining Grade 3 in more than one region.
- Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study.
- Abnormal lacrimal secretions.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Keratoconus or other corneal irregularity.
- Polymethyl methacrylate (PMMA) or Rigid Gas Permeable (RGP) lens wear in the previous 8 weeks
- Extended lens wear in last 3 months.
- Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
- Diabetic.
- Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
- Pregnancy, lactating or planning a pregnancy at the time of enrolment.
- Participation in any concurrent clinical trial or in last 60 days.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description balafilcon A toric balafilcon A toric balafilcon A, daily wear, toric contact lens worn for two weeks senofilcon A toric senofilcon A toric senofilcon A, daily wear, toric contact lens worn for two weeks
- Primary Outcome Measures
Name Time Method Lens Orientation 1 minute after insertion Proportion of eyes with lens orientation within 5 degrees of optimal
Lens Stability 10-15 minutes after insertion Lens stability is measured as the amount of rotation induced from blink after the lens has settled.
Subjective Comfort 2 weeks of lens wear Subjective comfort was derived from a weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response. \>0 = comfortable, \< 0 = uncomfortable. Combined measures from Week 1 and Week 5.
- Secondary Outcome Measures
Name Time Method Time to Fit Lens after lens insertion Time required for the optometrist to fit the lens.
Subjective Lens Vision measured at 1 and 2 weeks A weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response was used to derive vision outcomes. \>0 = satisfactory vision, \< 0 = unsatisfactory vision. Analysis is performed on combined 1 week and 2 week data.
Overall Corneal Staining After 2 weeks use National Eye Institute 0-3 Scale: Grade 0 = Normal, Grade 1 = Mild, superficial stippling, Grade 2 = Moderate, punctuate staining including superficial abrasion of the cornea, Grade 3 = Severe, abrasion or corneal erosion, deep corneal abrasion or recurrent erosion.
Trial Locations
- Locations (19)
Matus Eyecare
🇺🇸Franklin, Wisconsin, United States
Dr. Larry Menning
🇺🇸Chamberlain, South Dakota, United States
Camp Eye Care Clinic
🇺🇸North Little Rock, Arkansas, United States
James R. Dugue, O.D.
🇺🇸Mission Viejo, California, United States
Executive Park Eye Care
🇺🇸Colorado Springs, Colorado, United States
Dr. Ted Brink and Associates
🇺🇸Jacksonville, Florida, United States
Grene Vision Group
🇺🇸Neodesha, Kansas, United States
Advanced Eyecare, PC
🇺🇸Raytown, Missouri, United States
Dr. James Brobst
🇺🇸Florence, New Jersey, United States
Fine Eye Care Associates
🇺🇸Rochester, New York, United States
Selden Eyecare LLC
🇺🇸Kittanning, Pennsylvania, United States
Warren Ophthalmology Associates
🇺🇸Warren, Ohio, United States
Dr. David W. Ferris and Associates
🇺🇸Warwick, Rhode Island, United States
Nittany Eye Associates
🇺🇸State College, Pennsylvania, United States
Wishnow-Sugar Vision Group
🇺🇸Katy, Texas, United States
Dr. William Bogus
🇺🇸Salt Lake City, Utah, United States
Midlothian Optometric Center
🇺🇸Midlothian, Virginia, United States
The Eye Specialists, Ltd.
🇺🇸Virginia Beach, Virginia, United States
The Eye & Contact Lens Clinic
🇺🇸Bremerton, Washington, United States